Market Research Logo

Global Ortho Biological Products Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Ortho Biological Products Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

The global ortho biological products market is anticipated to grow to $15.4 billion during 2016- 2022. Due to Rising of ortho biological products is driven by growing awareness towards adoption of orthobiologics, development in technology, and increasing number of orthopedic related process. Further specific restraint such as high cost associated with the products. These products have high costs, that are beyond the affordability of few people and it is restricting the growth of the market.

The segments of the ortho biological products market are on the basis of the applications, products, and region. The products market segmentation is on the basis of Demineralized Bone Matrix, machined bones, allograft, Bone Morphogenetic Protein, machined bones, visco supplementation, stem cell therapy, and other applications

Orthopedic surgery was restricted to metal and screw implants to repair the damages and fractured bones, wherever, development in technology has propelled the field of orthopedics with the latest alternatives that are providing better comfort and durability.

Orthobiologics includes use of biology and biochemistry in development of bone and tissue replacement materials. This is the rapidly growing segment of the orthopedic industry as it has offered alternatives for traditional bone and tissue repair provide better durability. Orthobiologics is helping in rising the strength and ability of repair and minimize the length of the postoperative period.

Rising demand for minimally invasive surgeries is expected to provide new opportunities for technological innovations in the market and it additional makes new roads for development. Others effect rendering driver includes demographic and social changes in lifestyle of people, increasing spending power of people over healthcare, and rising disposable income. The benefits provided by ortho biological products, for example, decrease pain and faster healing and recoveries are few of the other factors that are anticipated to fuel the development of the market further.

On the basis of geography, the global market of ortho biological products is segmented into North America, Europe, Asia Pacific and Rest of the world. The North America is the leading region in the market of ortho biological products. The market expansion and the lead is expected to sustain during the coming period due to the increasing population base of geriatric patients, increasing prevalence of injuries, increasing medical device sales and growing number of orthopedic procedures. Europe has the second highest share in the market and is anticipated to maintain its place over the coming period. Asia Pacific is anticipated to be the rapidly growing region with specific emphasis on South Korea, Malaysia, China, and India. The drivers for the profitable growth in the region are attributed to the rising disposal income of people, increasing expenditure power of the patients over healthcare, rising medical tourism to these nations, and growing awareness level of the patients.

Major players overwhelming the ortho biological products business sector are Bioventus, Pioneer Surgical Technology, Baxter International, Inc., Smith and Nephew Plc, DePuySynthes, Inc., Allograft Tissue Systems, Bone Biologics, Inc., Integra Life Sciences Corp., Bone Solutions, Inc., Sanofi, Tissue Banks Osiris Therapeutics, Inc., International, Medtronic, Inc., Berkeley Advanced Biomaterials, Inc., Globus Medical, Tissue Genesis, Inc., Stryker Corp, and others. Acquisition, product launches are the major strategies which are followed the by companies.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. MARKET SCOPE
2. MARKET OVERVIEW
2.1. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET: EVOLUTION & TRANSITION
2.2. INDUSTRY STRUCTURE
2.3. MANUFACTURING PROCESS
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.6.1. SHARE OF ORTHOBIOLOGICAL PRODUCTS IN RECONSTRUCTIVE SURGERIES MARKET
2.6.2. DEMAND OF ORTHOBIOLOGICAL PRODUCTS IN TENDON & LIGAMENT REPAIR
2.6.3. REVENUE OF TOP 5 MARKET PLAYERS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7.7. ROI ANALYSIS
2.7.8. GAP ANALYSIS
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE
2.8.3. TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS& MARKET IMPACT
3.1.1. GROWING GERIATRIC POPULATION
3.1.2. INCREASING AWARENESS REGARDING ACCEPTANCE OF ORTHOBIOLOGICS
3.1.3. INCREASING DISPOSABLE INCOME
3.1.4. INCREASING NUMBER OF ORTHOPAEDIC RELATED PROCEDURES
3.1.5. BENEFITS ASSOCIATED SUCH AS REDUCED PAIN AND FASTER HEALING AND RECOVERY
3.1.6. TECHNOLOGICAL ADVANCEMENTS
3.2. MARKET RESTRAINTS & MARKET IMPACT
3.2.1. HIGH COST ASSOCIATED WITH THE PRODUCTS.
3.2.2. LACK OF AWARENESS
3.3. MARKET OPPORTUNITIES
3.3.1. RISING DEMAND FROM EMERGING MARKETS
3.3.2. RISING HEALTHCARE SPENDING BY PEOPLE ACROSS GEOGRAPHY
3.3.3. GROWING MEDICAL TOURISM
3.4. MARKET CHALLENGES
3.4.1. DEARTH OF TRAINED PERSONNEL
3.4.2. TECHNOLOGICAL COMPLEXITY
3.5. TECHNOLOGICAL COMPLEXITY
MARKET SEGMENTATION
3.6. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY ITS APPLICATION 2014-2022
($ MILLION)
3.6.1. MARKET DEFINITION AND SCOPE
3.6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
3.6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
3.6.4. OPPORTUNITY MATRIX
3.6.5. MARKET SEGMENTATION
3.6.5.1. RECONSTRUCTIVE SURGERIES 2014-2022 ($ MILLION)
3.6.5.1.1. APPLICATIONS
3.6.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.6.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.6.5.1.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
3.6.5.1.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
3.6.5.1.3.3. PRICE ANALYSIS
3.6.5.1.4. TOP PLAYERS & KEY PRODUCTS
3.6.5.1.5. KEY CONCLUSIONS
3.6.5.2. TRAUMA 2014-2022 ($ MILLION)
3.6.5.2.1. APPLICATIONS
3.6.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.6.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.6.5.2.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
3.6.5.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
3.6.5.2.3.3. PRICE ANALYSIS
3.6.5.2.4. TOP PLAYERS & KEY PRODUCTS
3.6.5.2.5. KEY CONCLUSIONS
3.6.5.3. SPINAL FUSION 2014-2022 ($ MILLION)
3.6.5.3.1. APPLICATIONS
3.6.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.6.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.6.5.3.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
3.6.5.3.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
3.6.5.3.3.3. PRICE ANALYSIS
3.6.5.3.4. TOP PLAYERS & KEY PRODUCTS
3.6.5.3.5. KEY CONCLUSIONS
3.6.5.4. TENDON & LIGAMENT REPAIR 2014-2022 ($ MILLION)
3.6.5.4.1. APPLICATIONS
3.6.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.6.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.6.5.4.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
3.6.5.4.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
3.6.5.4.3.3. PRICE ANALYSIS
3.6.5.4.4. TOP PLAYERS & KEY PRODUCTS
3.6.5.4.5. KEY CONCLUSIONS
3.6.5.5. OTHER APPLICATIONS 2014-2022 ($ MILLION)
3.6.5.5.1. APPLICATIONS
3.6.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.6.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.6.5.5.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
3.6.5.5.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
3.6.5.5.3.3. PRICE ANALYSIS
3.6.5.5.4. TOP PLAYERS & KEY PRODUCTS
3.6.5.5.5. KEY CONCLUSIONS
3.7. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY PRODUCT 2014-2022 ($ MILLION)
3.7.1. MARKET DEFINITION AND SCOPE
3.7.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
3.7.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
3.7.4. OPPORTUNITY MATRIX
3.7.5. MARKET SEGMENTATION
3.7.5.1. DBM 2014-2022 ($ MILLION)
3.7.5.1.1. APPLICATIONS
3.7.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.7.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.7.5.1.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
3.7.5.1.4. TOP PLAYERS & KEY PRODUCTS
3.7.5.1.5. KEY CONCLUSIONS
3.7.5.2. ALLOGRAFT 2014-2022 ($ MILLION)
3.7.5.2.1. APPLICATIONS
3.7.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.7.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.7.5.2.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
3.7.5.2.4. TOP PLAYERS & KEY PRODUCTS
3.7.5.2.5. KEY CONCLUSIONS
3.7.5.3. BMP 2014-2022 ($ MILLION)
3.7.5.3.1. APPLICATIONS
3.7.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.7.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.7.5.3.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
3.7.5.3.4. TOP PLAYERS & KEY PRODUCTS
3.7.5.3.5. KEY CONCLUSIONS
3.7.5.4. VISCOSUPPLEMENTATION 2014-2022 ($ MILLION)
3.7.5.4.1. APPLICATIONS
3.7.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.7.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.7.5.4.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
3.7.5.4.4. TOP PLAYERS & KEY PRODUCTS
3.7.5.4.5. KEY CONCLUSIONS
3.7.5.5. MACHINED BONES 2014-2022 ($ MILLION)
3.7.5.5.1. APPLICATIONS
3.7.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.7.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.7.5.5.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
3.7.5.5.4. TOP PLAYERS & KEY PRODUCTS
3.7.5.5.5. KEY CONCLUSIONS
3.7.5.6. STEM CELL THERAPY 2014-2022 ($ MILLION)
3.7.5.6.1. APPLICATIONS
3.7.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.7.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.7.5.6.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
3.7.5.6.4. TOP PLAYERS & KEY PRODUCTS
3.7.5.6.5. KEY CONCLUSIONS
3.7.5.7. OTHERS 2014-2022 ($ MILLION)
3.7.5.7.1. APPLICATIONS
3.7.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
3.7.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
3.7.5.7.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
3.7.5.7.4. TOP PLAYERS & KEY PRODUCTS
3.7.5.7.5. KEY CONCLUSIONS
4. COMPETITIVE LANDSCAPE
4.1. KEY STRATEGIES
4.1.1. LIST OF M&A
4.1.2. LIST OF JV
4.1.3. LIST OF PRODUCT LAUNCHES
4.1.4. LIST OF PARTNERSHIP
4.2. TOP 10 COMPANY ANALYSIS – DASHBOARD
5. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY REGION (REVENUE ANALYSIS), 2014-2022 ($ MILLION)
5.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
5.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
5.3. OPPORTUNITY MATRIX
5.4. GEOGRAPHIC ANALYSIS
5.4.1. NORTH AMERICA
5.4.1.1. INDUSTRY APPLICATION ANALYSIS
5.4.1.2. TOP COUNTRY ANALYSIS
5.4.1.2.1. U.S.
5.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.1.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.1.2.1.3. PRICE ANALYSIS
5.4.1.2.1.4. TOP PLAYERS & KEY PRODUCTS
5.4.1.2.1.5. KEY CONCLUSIONS
5.4.1.2.2. CANADA
5.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.1.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.1.2.2.3. PRICE ANALYSIS
5.4.1.2.2.4. TOP PLAYERS & KEY PRODUCTS
5.4.1.2.2.5. KEY CONCLUSIONS
5.4.2. EUROPE
5.4.2.1. INDUSTRY APPLICATION ANALYSIS
5.4.2.2. TOP COUNTRY ANALYSIS
5.4.2.2.1. UK
5.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.2.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.2.2.1.3. PRICE ANALYSIS
5.4.2.2.1.4. TOP PLAYERS & KEY PRODUCTS
5.4.2.2.1.5. KEY CONCLUSIONS
5.4.2.2.2. FRANCE
5.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.2.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.2.2.2.3. PRICE ANALYSIS
5.4.2.2.2.4. TOP PLAYERS & KEY PRODUCTS
5.4.2.2.2.5. KEY CONCLUSIONS
5.4.2.2.3. GERMANY
5.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.2.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.2.2.3.3. PRICE ANALYSIS
5.4.2.2.3.4. TOP PLAYERS & KEY PRODUCTS
5.4.2.2.3.5. KEY CONCLUSIONS
5.4.2.2.4. SPAIN
5.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.2.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.2.2.4.3. PRICE ANALYSIS
5.4.2.2.4.4. TOP PLAYERS & KEY PRODUCTS
5.4.2.2.4.5. KEY CONCLUSIONS
5.4.2.2.5. ITALY
5.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.2.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.2.2.5.3. PRICE ANALYSIS
5.4.2.2.5.4. TOP PLAYERS & KEY PRODUCTS
5.4.2.2.5.5. KEY CONCLUSIONS
5.4.2.2.6. REST OF EUROPE
5.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.2.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.2.2.6.3. PRICE ANALYSIS
5.4.2.2.6.4. TOP PLAYERS & KEY PRODUCTS
5.4.2.2.6.5. KEY CONCLUSIONS
5.4.3. ASIA PACIFIC
5.4.3.1. INDUSTRY APPLICATION ANALYSIS
5.4.3.2. TOP COUNTRY ANALYSIS
5.4.3.2.1. CHINA
5.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.3.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.3.2.1.3. PRICE ANALYSIS
5.4.3.2.1.4. TOP PLAYERS & KEY PRODUCTS
5.4.3.2.1.5. KEY CONCLUSIONS
5.4.3.2.2. INDIA
5.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.3.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.3.2.2.3. PRICE ANALYSIS
5.4.3.2.2.4. TOP PLAYERS & KEY PRODUCTS
5.4.3.2.2.5. KEY CONCLUSIONS
5.4.3.2.3. JAPAN
5.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.3.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.3.2.3.3. PRICE ANALYSIS
5.4.3.2.3.4. TOP PLAYERS & KEY PRODUCTS
5.4.3.2.3.5. KEY CONCLUSIONS
5.4.3.2.4. SOUTH KOREA
5.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.3.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.3.2.4.3. PRICE ANALYSIS
5.4.3.2.4.4. TOP PLAYERS & KEY PRODUCTS
5.4.3.2.4.5. KEY CONCLUSIONS
5.4.3.2.5. AUSTRALIA
5.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.3.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.3.2.5.3. PRICE ANALYSIS
5.4.3.2.5.4. TOP PLAYERS & KEY PRODUCTS
5.4.3.2.5.5. KEY CONCLUSIONS
5.4.3.2.6. REST OF ASIA PACIFIC
5.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.3.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.3.2.6.3. PRICE ANALYSIS
5.4.3.2.6.4. TOP PLAYERS & KEY PRODUCTS
5.4.3.2.6.5. KEY CONCLUSIONS
5.4.4. ROW
5.4.4.1. INDUSTRY APPLICATION ANALYSIS
5.4.4.2. TOP COUNTRY ANALYSIS
5.4.4.2.1. LATIN AMERICA
5.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.4.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.4.2.1.3. PRICE ANALYSIS
5.4.4.2.1.4. TOP PLAYERS & KEY PRODUCTS
5.4.4.2.1.5. KEY CONCLUSIONS
5.4.4.2.2. MIDDLE EAST & AFRICA
5.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
5.4.4.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
5.4.4.2.2.3. PRICE ANALYSIS
5.4.4.2.2.4. TOP PLAYERS & KEY PRODUCTS
5.4.4.2.2.5. KEY CONCLUSIONS
6. COMPANY PROFILES
6.1. BERKELEY ADVANCED BIOMATERIALS, INC.
6.1.1. OVERVIEW
6.1.2. PRODUCT PORTFOLIO
6.1.3. KEY INNOVATION SECTOR
6.1.4. STRATEGIC INITIATIVES
6.1.5. SCOT ANALYSIS
6.2. BAXTER INTERNATIONAL, INC
6.2.1. OVERVIEW
6.2.2. PRODUCT PORTFOLIO
6.2.3. KEY INNOVATION SECTOR
6.2.4. STRATEGIC INITIATIVES
6.2.5. SCOT ANALYSIS
6.3. BIOVENTUS
6.3.1. OVERVIEW
6.3.2. PRODUCT PORTFOLIO
6.3.3. KEY INNOVATION SECTOR
6.3.4. STRATEGIC INITIATIVES
6.3.5. SCOT ANALYSIS
6.4. BONE BIOLOGICS, INC.
6.4.1. OVERVIEW
6.4.2. PRODUCT PORTFOLIO
6.4.3. KEY INNOVATION SECTOR
6.4.4. STRATEGIC INITIATIVES
6.4.5. SCOT ANALYSIS
6.5. DEPUY SYNTHES, INC
6.5.1. OVERVIEW
6.5.2. PRODUCT PORTFOLIO
6.5.3. KEY INNOVATION SECTOR
6.5.4. STRATEGIC INITIATIVES
6.5.5. SCOT ANALYSIS
6.6. INTEGRA LIFESCIENCES CORP
6.6.1. OVERVIEW
6.6.2. PRODUCT PORTFOLIO
6.6.3. KEY INNOVATION SECTOR
6.6.4. STRATEGIC INITIATIVES
6.6.5. SCOT ANALYSIS
6.7. INTERVENTIONAL SPINE, INC
6.7.1. OVERVIEW
6.7.2. PRODUCT PORTFOLIO
6.7.3. KEY INNOVATION SECTOR
6.7.4. STRATEGIC INITIATIVES
6.7.5. SCOT ANALYSIS
6.8. MEDTRONIC, INC.
6.8.1. OVERVIEW
6.8.2. PRODUCT PORTFOLIO
6.8.3. KEY INNOVATION SECTOR
6.8.4. STRATEGIC INITIATIVES
6.8.5. SCOT ANALYSIS
6.9. OSIRIS THERAPEUTICS, INC.
6.9.1. OVERVIEW
6.9.2. PRODUCT PORTFOLIO
6.9.3. KEY INNOVATION SECTOR
6.9.4. STRATEGIC INITIATIVES
6.9.5. SCOT ANALYSIS
6.10. PIONEER SURGICAL TECHNOLOGY
6.10.1. OVERVIEW
6.10.2. PRODUCT PORTFOLIO
6.10.3. KEY INNOVATION SECTOR
6.10.4. STRATEGIC INITIATIVES
6.10.5. SCOT ANALYSIS
6.11. SANOFI
6.11.1. OVERVIEW
6.11.2. PRODUCT PORTFOLIO
6.11.3. KEY INNOVATION SECTOR
6.11.4. STRATEGIC INITIATIVES
6.11.5. SCOT ANALYSIS
6.12. SMITH AND NEPHEW PLC
6.12.1. OVERVIEW
6.12.2. PRODUCT PORTFOLIO
6.12.3. KEY INNOVATION SECTOR
6.12.4. STRATEGIC INITIATIVES
6.12.5. SCOT ANALYSIS
6.13. STRYKER CORP.
6.13.1. OVERVIEW
6.13.2. PRODUCT PORTFOLIO
6.13.3. KEY INNOVATION SECTOR
6.13.4. STRATEGIC INITIATIVES
6.13.5. SCOT ANALYSIS
6.14. TISSUE BANKS INTERNATIONAL
6.14.1. OVERVIEW
6.14.2. PRODUCT PORTFOLIO
6.14.3. KEY INNOVATION SECTOR
6.14.4. STRATEGIC INITIATIVES
6.14.5. SCOT ANALYSIS
6.15. TISSUE GENESIS, INC.
6.15.1. OVERVIEW
6.15.2. PRODUCT PORTFOLIO
6.15.3. KEY INNOVATION SECTOR
6.15.4. STRATEGIC INITIATIVES
6.15.5. SCOT ANALYSIS
LIST OF TABLES
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY APPLICATION ($ MILLION)
GLOBAL RECONSTRUCTIVE SURGERIES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL TRAUMA MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL SPINAL FUSION MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL TENDON & LIGAMENT REPAIR MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL OTHER APPLICATIONS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY PRODUCT ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET IN DBM BY GEOGRAPHY ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET IN ALLOGRAFT BY GEOGRAPHY ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET IN BMP BY GEOGRAPHY ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET IN VISCOSUPPLEMENTATION BY GEOGRAPHY ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET IN MACHINED BONES BY GEOGRAPHY ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET IN STEM CELL THERAPY BY GEOGRAPHY ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET IN OTHER PRODUCTS BY GEOGRAPHY ($ MILLION)
NORTH AMERICA ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
EUROPE ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
ASIA PACIFIC ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
REST OF THE WORLD ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY RECONSTRUCTIVE SURGERIES ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY TRAUMA ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY SPINAL FUSION ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY TENDON & LIGAMENT REPAIR ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY OTHERS ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY DBM ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY ALLOGRAFT ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY BMP ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY VISCOSUPPLEMENTATION ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY MACHINED BONES ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY STEM CELL THERAPY ($ MILLION)
GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY OTHERS ($ MILLION)
UNITED STATES (U.S.) ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
CANADA ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
UNITED KINGDOM (UK) ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
FRANCE ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
GERMANY ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
SPAIN ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
ITALY ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
ROEORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
INDIA ORTHOBIOLOGICAL PRODUCTS MARKET ($MILLION)
CHINA ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
JAPAN ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
KOREA ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
AUSTRALIA ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
ROAPACORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
LATIN AMERICA ORTHOBIOLOGICAL PRODUCTS MARKET ($ MILLION)
MENA ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2022 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report